Sorry, this entry is only available in Ukrainian.
Cлово редактора....Валентин Могилюк, к. фарм. н., запрошений редактор випуску журналу, присвяченого висвітленню питань щодо твердих лікарських форм
Вас может заинтересовать:
WEB only
Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Roughly a year after disclosing plans to…
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
